129 related articles for article (PubMed ID: 34594933)
21. Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults.
Steingart KR; Sohn H; Schiller I; Kloda LA; Boehme CC; Pai M; Dendukuri N
Cochrane Database Syst Rev; 2013 Jan; (1):CD009593. PubMed ID: 23440842
[TBL] [Abstract][Full Text] [Related]
22. Continuous surveillance of drug-resistant TB burden in Rwanda: a retrospective cross-sectional study.
Habimana-Mucyo Y; Dushime A; Migambi P; Habiyambere I; Semuto Ngabonziza JC; Decroo T
Int Health; 2023 Jul; 15(4):357-364. PubMed ID: 35653710
[TBL] [Abstract][Full Text] [Related]
23. Treatment of drug-resistant tuberculosis in children and young adolescents in Brazil.
Bruzadelli Paulino da Costa F; Zamboni Berra T; Garcia de Almeida Ballestero J; Bartholomay Oliveira P; Maria Pelissari D; Mathias Alves Y; Carlos Vieira Ramos A; Queiroz Rocha de Paiva J; Kehinde Ayandeyi Teibo T; Alexandre Arcêncio R
J Clin Tuberc Other Mycobact Dis; 2023 Dec; 33():100388. PubMed ID: 37588725
[TBL] [Abstract][Full Text] [Related]
24. Trends of Mycobacterium tuberculosis and Rifampicin resistance in Northwest Ethiopia: Xpert® MTB/RIF assay results from 2015 to 2021.
Biset S; Teferi M; Alamirew H; Birhanu B; Dessie A; Aschale A; Haymanot A; Dejenie S; Gebremedhin T; Abebe W; Adane G
BMC Infect Dis; 2024 Feb; 24(1):238. PubMed ID: 38389060
[TBL] [Abstract][Full Text] [Related]
25. Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults.
Steingart KR; Schiller I; Horne DJ; Pai M; Boehme CC; Dendukuri N
Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD009593. PubMed ID: 24448973
[TBL] [Abstract][Full Text] [Related]
26. Epidemiology of Drug-Resistant Tuberculosis.
Dean AS; Cox H; Zignol M
Adv Exp Med Biol; 2017; 1019():209-220. PubMed ID: 29116637
[TBL] [Abstract][Full Text] [Related]
27. A Tuberculosis Outbreak at a School - Xinjiang Uygur Autonomous Region, China, 2019.
Wang S; Cui Y; Liu N; Wang X; Wang X; Wu W; Zhang C; Parehati M; Li Z; Yu C; Zhang L; Cheng J
China CDC Wkly; 2020 Nov; 2(46):881-883. PubMed ID: 34594790
[TBL] [Abstract][Full Text] [Related]
28. Is rifampin resistance a reliable predictive marker of multidrug-resistant tuberculosis in China: A meta-analysis of findings.
Liu Z; Dong H; Wu B; Zhang M; Zhu Y; Pang Y; Wang X
J Infect; 2019 Oct; 79(4):349-356. PubMed ID: 31400354
[TBL] [Abstract][Full Text] [Related]
29. Transmission and Drug Resistance Genotype of Multidrug-Resistant or Rifampicin-Resistant Mycobacterium tuberculosis in Chongqing, China.
Zhao B; Liu C; Fan J; Ma A; He W; Hu Y; Zhao Y
Microbiol Spectr; 2022 Oct; 10(5):e0240521. PubMed ID: 36214695
[TBL] [Abstract][Full Text] [Related]
30. [Population-based molecular epidemiologic study of rifampicin-resistant tuberculosis in rural area of eastern China].
Wang JJ; Hu Y; Jiang WL; Wang WB; Xu B
Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Nov; 30(11):1189-93. PubMed ID: 20193593
[TBL] [Abstract][Full Text] [Related]
31. Should treatment of low-level rifampicin mono-resistant tuberculosis be different?
Gopie FA; Commiesie E; Baldi S; Kamst M; Kaur D; de Lange WCM; Pinas PS; Stijnberg D; Wongsokarijo M; Zijlmans CWR; de Zwaan R; van Soolingen D; Vreden SGS; de Vries G
J Clin Tuberc Other Mycobact Dis; 2021 May; 23():100222. PubMed ID: 33598570
[TBL] [Abstract][Full Text] [Related]
32. Sputum culture and drug sensitivity testing outcome among X-pert Mycobacterium tuberculosis/rifampicin-positive, rifampicin-resistant sputum: A retrospective study - Not all rifampicin resistance is multi-drug resistant.
Kenaope L; Ferreira H; Seedat F; Otwombe K; Martinson NA; Variava E
J Glob Antimicrob Resist; 2020 Jun; 21():434-438. PubMed ID: 31733411
[TBL] [Abstract][Full Text] [Related]
33. Analysis of Drug-Resistant Tuberculosis in Children in Shenyang, China, 2017-2021.
Sun J; Fan L; Zhao Y; Wu H; Li R; Tian Y; Cheng M; Ma X; Ma Y; Yang X; Shen A; Yu Y; Chen Y
Infect Drug Resist; 2023; 16():6983-6998. PubMed ID: 37933293
[TBL] [Abstract][Full Text] [Related]
34. Genetic polymorphism of human leucocyte antigen and susceptibility to multidrug-resistant and rifampicin-resistant tuberculosis in Han Chinese from Hubei Province.
Zhou X; Zhou Q; Yang ZF; Li WX
Int J Immunogenet; 2018 Feb; 45(1):8-21. PubMed ID: 29219243
[TBL] [Abstract][Full Text] [Related]
35. Prevalence of rifampicin resistant Mycobacterium tuberculosis among presumptive tuberculosis patients in selected governmental hospitals in Addis Ababa, Ethiopia.
Arega B; Menbere F; Getachew Y
BMC Infect Dis; 2019 Apr; 19(1):307. PubMed ID: 30947695
[TBL] [Abstract][Full Text] [Related]
36. Potential Application of Digitally Linked Tuberculosis Diagnostics for Real-Time Surveillance of Drug-Resistant Tuberculosis Transmission: Validation and Analysis of Test Results.
Ng KC; Meehan CJ; Torrea G; Goeminne L; Diels M; Rigouts L; de Jong BC; André E
JMIR Med Inform; 2018 Feb; 6(1):e12. PubMed ID: 29487047
[TBL] [Abstract][Full Text] [Related]
37. Recurrence Is a Noticeable Cause of Rifampicin-Resistant
Chen Q; Peng L; Xiong G; Peng Y; Luo D; Zou L; Chen K
Front Public Health; 2019; 7():182. PubMed ID: 31380332
[No Abstract] [Full Text] [Related]
38. Chest X-ray findings in drug-sensitive and drug-resistant pulmonary tuberculosis patients in Uganda.
Oriekot A; Sereke SG; Bongomin F; Bugeza S; Muyinda Z
J Clin Tuberc Other Mycobact Dis; 2022 May; 27():100312. PubMed ID: 35355939
[TBL] [Abstract][Full Text] [Related]
39. [Study on the efficacy and safety of short-term treatment including fluoroquinolones anti-tuberculosis drugs for rifampicin resistant pulmonary tuberculosis].
Kang WL; Xie YG; Tan WG; Chu NH; Li L; You YH; Yang YZ; Wang XM; Yan XL; Miao ZP; Duanmu HJ
Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Feb; 30(2):179-83. PubMed ID: 19565883
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
